Delivery Order SPE2DB20D1051-SPE2DB24FD7AH
- Not listed
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to supply 4,564,084,872 units of Fluticasone Prop HFA 220 MCG 12GM. The contract, valued at $30,713.34, has an ultimate completion date of March 27, 2024. Amerisourcebergen Drug Corp is the prime contractor on this delivery order, which is part of a larger indefinite delivery contract (IDC) valued at up to $999,999,999.00 and awarded...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the delivery of FLUTICASONE PROP HFA 220 MCG 12GM medication. The order, valued at $4,462.34, has a completion date of February 8, 2024. Amerisourcebergen Drug Corp is the prime contractor for this delivery order, which is not associated with any set-aside program. The company also holds an indefinite delivery contract (IDC) with DLA,...
- The Defense Logistics Agency (DLA) awarded a $4,973.03 firm-fixed-price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide Fluticasone Prop HFA 110 MCG 12GM. The contract is for the delivery of pharmaceutical products and has a completion date of January 26, 2024. Amerisourcebergen Drug Corp is the prime contractor and does not have any major subcontractors listed. This order is part of a larger indefinite delivery contract (IDC) awarded by...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $1,403.21 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical distribution company. The contract is for the provision of Fluticasone Prop HFA 110 MCG 12GM pharmaceutical products, with a completion date of February 28, 2024. Amerisourcebergen Drug Corp is the prime contractor on an indefinite delivery contract (IDC) with DLA valued at up to...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to supply FLUTICASONE PROP HFA 44 MCG 10.6GM, a pharmaceutical product. The contract has a potential value of $1,600.62 and a completion date of March 4, 2024. Amerisourcebergen Drug Corp also holds an indefinite delivery contract (IDC) with DLA valued up to $999,999,999.00 through December 31, 2025, which serves as the primary...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide Fluticasone Prop HFA 110 MCG 12GM pharmaceuticals. The $6,296.40 award has a completion date of March 8, 2024. Amerisourcebergen Drug Corp is the prime contractor and holds an indefinite delivery contract (IDC) with DLA valued at up to $999,999,999.00 through December 31, 2025 to deliver a comprehensive range of medications...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract valued at $4,890.73 to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the delivery of 4,564,186,359 units of Fluticasone Prop HFA 44 MCG 10.6GM pharmaceutical products. This delivery order contract has an ultimate completion date of April 8, 2024 and was awarded on April 5, 2024. The contract does not have a set-aside designation. AmerisourceBergen Drug Corp also holds an...
- The Department of Defense's Defense Logistics Agency (DLA) awarded a firm fixed price delivery order for $1,595.67 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide FLUTICASONE PROP HFA 44 MCG 10.6GM pharmaceutical products. This delivery order is part of Amerisourcebergen's existing indefinite delivery contract with DLA to supply pharmaceuticals and medical supplies to support military treatment programs and facilities. The award has a completion date...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of Fluticasone Prop HFA 110 mcg 12gm pharmaceutical products. The contract has a potential value of $2,124.52 and a period of performance through February 27, 2024. Amerisourcebergen Drug Corp, a for-profit organization, is the prime contractor on this delivery order, which does not...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide a pharmaceutical product - Fluticasone Prop HFA 110 MCG 12GM. The contract has a potential value of $3,937.85 and a completion date of February 20, 2024. Amerisourcebergen Drug Corp serves as a prime contractor providing a wide range of pharmaceuticals and medical supplies to U.S. government agencies, notably the Department of...
- SPE2DB20D1051Indefinite Delivery Contract
- SPE2DB20D1051-SPE2DB24FD7AHDelivery Order
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $1,923.12 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4563652915 - FLUTICASONE PROP HFA 220 MCG 12GM. This contract has a completion date of February 14, 2024. Amerisourcebergen Drug Corp, a for-profit organization, serves as the prime contractor for this delivery order, which is not associated with any set-aside program. In addition, Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with a potential value of $999,999,999.00 from DLA to deliver a comprehensive range of pharmaceutical products and medical supplies to military treatment programs and facilities worldwide through December 31, 2025.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.9k | 2/13/24 |